迪戈辛和运动对骨肌肉的影响 Na+,K+-ATPase异形基因表达在健康人群中
Michael J McKenna1, Xiaofei Gong1, Aaron C Petersen1
1Institute for Health and Sport, Victoria University, Melbourne, Australia.
Experimental physiology
|September 2, 2024
概括
迪戈辛在运动期间没有改变肌肉Na+,K+-ATPase (NKA) 基因表达. 然而,静止肌肉与狄戈辛的NKAβ子单元mRNA总量增加,这表明对β基因表达有潜在的刺激作用.
科学领域:
- 运动生理学 运动生理学
- 分子生物学分子生物学
- 心血管药理学心血管药理学
背景情况:
- 肌肉Na+,K+-ATPase (NKA) 对于离子稳态至关重要.
- 迪戈辛抑制了NKA,而运动可以提高NKA基因表达的调节.
研究的目的:
- 调查狄戈辛是否会影响NKA异形mRNA在休息,运动期间和运动后的肌肉中的表达.
- 为了确定狄戈辛是否会改变肌肉对急性运动的NKA基因反应.
主要方法:
- 在10名健康成年人中进行了随机,双盲,交叉研究.
- 参与者接受了迪戈辛或安慰剂14天.
- 肌肉活检分析了NKA异型mRNA (qPCR) 和静止时,运动期间和运动后的蛋白质.
主要成果:
- 与安慰剂相比,迪戈辛没有改变NKAα1-3或β1-3mRNA水平.
- 运动后,α1和β3mRNA增加,而疲劳时α3mRNA减少.
- 休息肌肉与狄戈辛增加了总β mRNA,但不是总α mRNA.
结论:
- 迪戈辛在运动反应中没有改变NKA基因表达.
- 静止总β mRNA的升高表明狄戈辛对NKAβ基因表达具有潜在的刺激作用.
- 肌肉NKA基因调节似乎与蛋白质含量保持一致,尽管有压力因素.
相关概念视频
Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545
Exercise and Cardiovascular Response
750
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
750
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
935
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
935
Skeletal Muscle Relaxants: Adverse Effects
348
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
348
Pathophysiology of Cardiac Performance
616
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
616
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K


